290 related articles for article (PubMed ID: 20211898)
1. Antiviral activity of a small-molecule inhibitor of filovirus infection.
Warren TK; Warfield KL; Wells J; Enterlein S; Smith M; Ruthel G; Yunus AS; Kinch MS; Goldblatt M; Aman MJ; Bavari S
Antimicrob Agents Chemother; 2010 May; 54(5):2152-9. PubMed ID: 20211898
[TBL] [Abstract][Full Text] [Related]
2. Filovirus Virulence in Interferon α/β and γ Double Knockout Mice, and Treatment with Favipiravir.
Comer JE; Escaffre O; Neef N; Brasel T; Juelich TL; Smith JK; Smith J; Kalveram B; Perez DD; Massey S; Zhang L; Freiberg AN
Viruses; 2019 Feb; 11(2):. PubMed ID: 30717492
[TBL] [Abstract][Full Text] [Related]
3. Drug targets in infections with Ebola and Marburg viruses.
Gene OG; Julia BE; Vanessa MR; Victoria WJ; Thomas GW; Lisa HE
Infect Disord Drug Targets; 2009 Apr; 9(2):191-200. PubMed ID: 19275706
[TBL] [Abstract][Full Text] [Related]
4. Lethality and pathogenesis of airborne infection with filoviruses in A129 α/β -/- interferon receptor-deficient mice.
Lever MS; Piercy TJ; Steward JA; Eastaugh L; Smither SJ; Taylor C; Salguero FJ; Phillpotts RJ
J Med Microbiol; 2012 Jan; 61(Pt 1):8-15. PubMed ID: 21852521
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Ebola and Marburg Virus Entry by G Protein-Coupled Receptor Antagonists.
Cheng H; Lear-Rooney CM; Johansen L; Varhegyi E; Chen ZW; Olinger GG; Rong L
J Virol; 2015 Oct; 89(19):9932-8. PubMed ID: 26202243
[TBL] [Abstract][Full Text] [Related]
6. A biaryl sulfonamide derivative as a novel inhibitor of filovirus infection.
Isono M; Furuyama W; Kuroda M; Kondoh T; Igarashi M; Kajihara M; Yoshida R; Manzoor R; Okuya K; Miyamoto H; Feldmann H; Marzi A; Sakaitani M; Nanbo A; Takada A
Antiviral Res; 2020 Nov; 183():104932. PubMed ID: 32946918
[TBL] [Abstract][Full Text] [Related]
7. Identification of an antioxidant small-molecule with broad-spectrum antiviral activity.
Panchal RG; Reid SP; Tran JP; Bergeron AA; Wells J; Kota KP; Aman J; Bavari S
Antiviral Res; 2012 Jan; 93(1):23-9. PubMed ID: 22027648
[TBL] [Abstract][Full Text] [Related]
8. Stat1-Deficient Mice Are Not an Appropriate Model for Efficacy Testing of Recombinant Vesicular Stomatitis Virus-Based Filovirus Vaccines.
Marzi A; Kercher L; Marceau J; York A; Callsion J; Gardner DJ; Geisbert TW; Feldmann H
J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S404-9. PubMed ID: 26022440
[TBL] [Abstract][Full Text] [Related]
9. Advanced antisense therapies for postexposure protection against lethal filovirus infections.
Warren TK; Warfield KL; Wells J; Swenson DL; Donner KS; Van Tongeren SA; Garza NL; Dong L; Mourich DV; Crumley S; Nichols DK; Iversen PL; Bavari S
Nat Med; 2010 Sep; 16(9):991-4. PubMed ID: 20729866
[TBL] [Abstract][Full Text] [Related]
10. Filovirus infection of STAT-1 knockout mice.
Raymond J; Bradfute S; Bray M
J Infect Dis; 2011 Nov; 204 Suppl 3():S986-90. PubMed ID: 21987780
[TBL] [Abstract][Full Text] [Related]
11. Development of treatment strategies to combat Ebola and Marburg viruses.
Paragas J; Geisbert TW
Expert Rev Anti Infect Ther; 2006 Feb; 4(1):67-76. PubMed ID: 16441210
[TBL] [Abstract][Full Text] [Related]
12. Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430.
Warren TK; Wells J; Panchal RG; Stuthman KS; Garza NL; Van Tongeren SA; Dong L; Retterer CJ; Eaton BP; Pegoraro G; Honnold S; Bantia S; Kotian P; Chen X; Taubenheim BR; Welch LS; Minning DM; Babu YS; Sheridan WP; Bavari S
Nature; 2014 Apr; 508(7496):402-5. PubMed ID: 24590073
[TBL] [Abstract][Full Text] [Related]
13. Current status of small molecule drug development for Ebola virus and other filoviruses.
Edwards MR; Basler CF
Curr Opin Virol; 2019 Apr; 35():42-56. PubMed ID: 31003196
[TBL] [Abstract][Full Text] [Related]
14. Cholesterol-conjugated stapled peptides inhibit Ebola and Marburg viruses in vitro and in vivo.
Pessi A; Bixler SL; Soloveva V; Radoshitzky S; Retterer C; Kenny T; Zamani R; Gomba G; Gharabeih D; Wells J; Wetzel KS; Warren TK; Donnelly G; Van Tongeren SA; Steffens J; Duplantier AJ; Kane CD; Vicat P; Couturier V; Kester KE; Shiver J; Carter K; Bavari S
Antiviral Res; 2019 Nov; 171():104592. PubMed ID: 31473342
[TBL] [Abstract][Full Text] [Related]
15. Filovirus proteins for antiviral drug discovery: Structure/function bases of the replication cycle.
Martin B; Canard B; Decroly E
Antiviral Res; 2017 May; 141():48-61. PubMed ID: 28192094
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of favipiravir (T-705) in nonhuman primates infected with Ebola virus or Marburg virus.
Bixler SL; Bocan TM; Wells J; Wetzel KS; Van Tongeren SA; Dong L; Garza NL; Donnelly G; Cazares LH; Nuss J; Soloveva V; Koistinen KA; Welch L; Epstein C; Liang LF; Giesing D; Lenk R; Bavari S; Warren TK
Antiviral Res; 2018 Mar; 151():97-104. PubMed ID: 29289666
[TBL] [Abstract][Full Text] [Related]
17. Development and characterization of a mouse model for Marburg hemorrhagic fever.
Warfield KL; Bradfute SB; Wells J; Lofts L; Cooper MT; Alves DA; Reed DK; VanTongeren SA; Mech CA; Bavari S
J Virol; 2009 Jul; 83(13):6404-15. PubMed ID: 19369350
[TBL] [Abstract][Full Text] [Related]
18. Filovirus-like particles produced in insect cells: immunogenicity and protection in rodents.
Warfield KL; Posten NA; Swenson DL; Olinger GG; Esposito D; Gillette WK; Hopkins RF; Costantino J; Panchal RG; Hartley JL; Aman MJ; Bavari S
J Infect Dis; 2007 Nov; 196 Suppl 2():S421-9. PubMed ID: 17940979
[TBL] [Abstract][Full Text] [Related]
19. A Single-Vector, Single-Injection Trivalent Filovirus Vaccine: Proof of Concept Study in Outbred Guinea Pigs.
Mire CE; Geisbert JB; Versteeg KM; Mamaeva N; Agans KN; Geisbert TW; Connor JH
J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S384-8. PubMed ID: 25957964
[TBL] [Abstract][Full Text] [Related]
20. Identification of a coumarin-based antihistamine-like small molecule as an anti-filoviral entry inhibitor.
Cheng H; Schafer A; Soloveva V; Gharaibeh D; Kenny T; Retterer C; Zamani R; Bavari S; Peet NP; Rong L
Antiviral Res; 2017 Sep; 145():24-32. PubMed ID: 28645623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
